Lassen U - Search Results

1

A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.

Mirza MR, Bergmann TK, Mau-Sørensen M, Christensen RD, Åvall-Lundqvist E, Birrer MJ, Jørgensen M, Roed H, Malander S, Nielsen F, Lassen U, Brøsen K, Bjørge L, Mäenpää J. Mirza MR, et al. Among authors: lassen u. Cancer Chemother Pharmacol. 2019 Oct;84(4):791-798. doi: 10.1007/s00280-019-03917-z. Epub 2019 Aug 2. Cancer Chemother Pharmacol. 2019. PMID: 31375879 Clinical Trial.

2

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression.

Lassen UN, Osterlind K, Hirsch FR, Bergman B, Dombernowsky P, Hansen HH. Lassen UN, et al. Br J Cancer. 1999 Feb;79(3-4):515-9. doi: 10.1038/sj.bjc.6690080. Br J Cancer. 1999. PMID: 10027322 Free PMC article.

3

Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.

Sorensen M, Lassen U, Palshof T, Jensen BB, Johansen J, Jensen PB, Langer SW. Sorensen M, et al. Among authors: lassen u. Lung Cancer. 2008 May;60(2):252-8. doi: 10.1016/j.lungcan.2007.09.022. Epub 2007 Nov 26. Lung Cancer. 2008. PMID: 18036701 Clinical Trial.

4

Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease.

Sorensen M, Lassen U, Jensen PB, Østerlind K, Jeppesen N, Jensen BB, Mellemgaard A, Rytter C, Langer SW. Sorensen M, et al. Among authors: lassen u. J Thorac Oncol. 2008 Aug;3(8):902-6. doi: 10.1097/JTO.0b013e31817e0f58. J Thorac Oncol. 2008. PMID: 18670309 Free article. Clinical Trial.

5

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours.

Lassen U, Molife LR, Sorensen M, Engelholm SA, Vidal L, Sinha R, Penson RT, Buhl-Jensen P, Crowley E, Tjornelund J, Knoblauch P, de Bono JS. Lassen U, et al. Br J Cancer. 2010 Jun 29;103(1):12-7. doi: 10.1038/sj.bjc.6605726. Epub 2010 Jun 15. Br J Cancer. 2010. PMID: 20588278 Free PMC article. Clinical Trial.

6

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers.

Rohrberg KS, Olesen RK, Pfeiffer P, Ladekarl M, Pappot H, Christensen IJ, Høyer-Hansen G, Sørensen M, Skov BG, Buysschaert I, Carmeliet P, Lassen U. Rohrberg KS, et al. Among authors: lassen u. Acta Oncol. 2012 Feb;51(2):234-42. doi: 10.3109/0284186X.2011.619568. Epub 2011 Oct 21. Acta Oncol. 2012. PMID: 22017239 Clinical Trial.

7

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.

Lassen U, Nielsen DL, Sørensen M, Winstedt L, Niskanen T, Stenberg Y, Pakola S, Stassen JM, Glazer S. Lassen U, et al. Br J Cancer. 2012 Feb 14;106(4):678-84. doi: 10.1038/bjc.2011.609. Epub 2012 Jan 24. Br J Cancer. 2012. PMID: 22333707 Free PMC article. Clinical Trial.

8

A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.

Møller S, Grunnet K, Hansen S, Schultz H, Holmberg M, Sorensen M, Poulsen HS, Lassen U. Møller S, et al. Among authors: lassen u. Acta Oncol. 2012 Jul;51(6):797-804. doi: 10.3109/0284186X.2012.681063. Epub 2012 May 1. Acta Oncol. 2012. PMID: 22548369 Clinical Trial.

9

A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer.

Holländer C, Baeksgaard L, Sorensen M, Albertsson P, Damstrup L, Lassen U. Holländer C, et al. Among authors: lassen u. Anticancer Res. 2012 Sep;32(9):4019-23. Anticancer Res. 2012. PMID: 22993353 Clinical Trial.

10

Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours.

Lassen U, Miller WH, Hotte S, Evans TR, Kollmansberger C, Adamson D, Nielsen DL, Spicer J, Chen E, Meyer T, Brown K, Rafi R, Sawyer MB. Lassen U, et al. Cancer Chemother Pharmacol. 2013 Feb;71(2):543-9. doi: 10.1007/s00280-012-2038-0. Epub 2012 Nov 30. Cancer Chemother Pharmacol. 2013. PMID: 23196640 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page